Spironolactone therapy in infants with congestive heart failure secondary to congenital heart disease.-Reference-Cited by-同舟云学术

Spironolactone therapy in infants with congestive heart failure secondary to congenital heart disease.

Published:1981-12-01 Issue:12 Volume:56 Page:934-938
ISSN:0003-9888
Container-title:Archives of Disease in Childhood
language:en
Short-container-title:Archives of Disease in Childhood

Author:

Hobbins S M,Fowler R S,Rowe R D,Korey A G

Publisher

BMJ

Subject

Pediatrics, Perinatology, and Child Health

Reference16 articles.

1. Pharmacology of a new steroid that blocks salt activity of aldosterone and desoxycorticosterone;M, Kagawa C.; M, Sturtevant F.; G, Van Arman C.;J Pharmacol Exp Ther,1959

2. Aldosterone antagonists;W, Liddle G.;AMA Arch Intern Med,1958

3. Persistent systemic hypertension in infants and children;P, Rance C.; S, Arbus G.; W, Balfe J.; W, Kooh S.;Pediatr Clin North Am,1974

4. Drug therapy of heart disease in pediatric patients. 1. Congestive heart failure in infancy and concepts of developmental pharmacology;N, Cohen S.; F, Doyle E.; M, Rutowski M.;Am Heart J,1973

5. Stop flow analysis of aldosterone and steroidal antagonist SC-8109 on renal tubular;J, Vander A.; S, Wilde W.; L, Malvin R.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse Drug Reactions in Children with Congenital Heart Disease: A Scoping Review;Pediatric Drugs;2024-07-23

2. Characterization of spironolactone and metabolites derivatized using Girard's reagent P using mass spectrometry and ion mobility spectrometry;Rapid Communications in Mass Spectrometry;2024-05-28

3. Model-Informed Optimization of a Pediatric Clinical Pharmacokinetic Trial of a New Spironolactone Liquid Formulation;Pharmaceutics;2021-06-08

4. Hypochloremia Secondary to Diuretics in Preterm Infants: Should Clinicians Pay Close Attention?;Global Pediatric Health;2021-01

5. Outpatient Management of Pediatric HF;Heart Failure in the Child and Young Adult;2018